Cargando…

A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters”

In this commentary, we critique a recently finalized document titled “State of the Art Assessment of Endocrine Disrupters” (SOA Assessment). The SOA Assessment was commissioned by the European Union Directorate-General for the Environment to provide a basis for developing scientific criteria for ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhomberg, Lorenz R., Goodman, Julie E., Foster, Warren G., Borgert, Christopher J., Van Der Kraak, Glen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408894/
https://www.ncbi.nlm.nih.gov/pubmed/22630047
http://dx.doi.org/10.3109/10408444.2012.690367
_version_ 1782239502048165888
author Rhomberg, Lorenz R.
Goodman, Julie E.
Foster, Warren G.
Borgert, Christopher J.
Van Der Kraak, Glen
author_facet Rhomberg, Lorenz R.
Goodman, Julie E.
Foster, Warren G.
Borgert, Christopher J.
Van Der Kraak, Glen
author_sort Rhomberg, Lorenz R.
collection PubMed
description In this commentary, we critique a recently finalized document titled “State of the Art Assessment of Endocrine Disrupters” (SOA Assessment). The SOA Assessment was commissioned by the European Union Directorate-General for the Environment to provide a basis for developing scientific criteria for identifying endocrine disruptors and reviewing and possibly revising the European Community Strategy on Endocrine Disrupters. In our view, the SOA Assessment takes an anecdotal approach rather than attempting a comprehensive assessment of the state of the art or synthesis of current knowledge.To do the latter, the document would have had to (i) distinguish between apparent associations of outcomes with exposure and the inference of an endocrine-disruption (ED) basis for those outcomes; (ii) constitute a complete and unbiased survey of new literature since 2002 (when the WHO/IPCS document, “Global Assessment of the State-of-the-Science of Endocrine Disruptors” was published); (iii) consider strengths and weaknesses and issues in interpretation of the cited literature; (iv) follow a weight-of-evidence methodology to evaluate evidence of ED; (v) document the evidence for its conclusions or the reasoning behind them; and (vi) present the evidence for or reasoning behind why conclusions that differ from those drawn in the 2002 WHO/IPCS document need to be changed. In its present form, the SOA Assessment fails to provide a balanced and critical assessment or synthesis of literature relevant to ED. We urge further evidence-based evaluations to develop the needed scientific basis to support future policy decisions.
format Online
Article
Text
id pubmed-3408894
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-34088942012-07-31 A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” Rhomberg, Lorenz R. Goodman, Julie E. Foster, Warren G. Borgert, Christopher J. Van Der Kraak, Glen Crit Rev Toxicol Review Article In this commentary, we critique a recently finalized document titled “State of the Art Assessment of Endocrine Disrupters” (SOA Assessment). The SOA Assessment was commissioned by the European Union Directorate-General for the Environment to provide a basis for developing scientific criteria for identifying endocrine disruptors and reviewing and possibly revising the European Community Strategy on Endocrine Disrupters. In our view, the SOA Assessment takes an anecdotal approach rather than attempting a comprehensive assessment of the state of the art or synthesis of current knowledge.To do the latter, the document would have had to (i) distinguish between apparent associations of outcomes with exposure and the inference of an endocrine-disruption (ED) basis for those outcomes; (ii) constitute a complete and unbiased survey of new literature since 2002 (when the WHO/IPCS document, “Global Assessment of the State-of-the-Science of Endocrine Disruptors” was published); (iii) consider strengths and weaknesses and issues in interpretation of the cited literature; (iv) follow a weight-of-evidence methodology to evaluate evidence of ED; (v) document the evidence for its conclusions or the reasoning behind them; and (vi) present the evidence for or reasoning behind why conclusions that differ from those drawn in the 2002 WHO/IPCS document need to be changed. In its present form, the SOA Assessment fails to provide a balanced and critical assessment or synthesis of literature relevant to ED. We urge further evidence-based evaluations to develop the needed scientific basis to support future policy decisions. Informa Healthcare 2012-07 2012-05-26 /pmc/articles/PMC3408894/ /pubmed/22630047 http://dx.doi.org/10.3109/10408444.2012.690367 Text en © 2012 Informa Healthcare USA, Inc. http://creativecommons.org/licenses/by/2.0/ This is an open access article distributed under the Supplemental Terms and Conditions for iOpenAccess articles published in Informa Healthcare journals (http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Rhomberg, Lorenz R.
Goodman, Julie E.
Foster, Warren G.
Borgert, Christopher J.
Van Der Kraak, Glen
A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters”
title A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters”
title_full A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters”
title_fullStr A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters”
title_full_unstemmed A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters”
title_short A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters”
title_sort critique of the european commission document, “state of the art assessment of endocrine disrupters”
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408894/
https://www.ncbi.nlm.nih.gov/pubmed/22630047
http://dx.doi.org/10.3109/10408444.2012.690367
work_keys_str_mv AT rhomberglorenzr acritiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT goodmanjuliee acritiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT fosterwarreng acritiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT borgertchristopherj acritiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT vanderkraakglen acritiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT rhomberglorenzr critiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT goodmanjuliee critiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT fosterwarreng critiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT borgertchristopherj critiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters
AT vanderkraakglen critiqueoftheeuropeancommissiondocumentstateoftheartassessmentofendocrinedisrupters